PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C

被引：0
|
作者：
Kurosaki, M. [1 ]
Itakura, J. [1 ]
Tsuchiya, K. [1 ]
Nakanishi, H. [1 ]
Asahina, Y. [1 ]
Mizokami, M. [2 ]
Tanaka, Y. [3 ]
Izumi, N. [1 ]
机构：
[1] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[2] Res Ctr Hepatitis & Immunol, Chiba, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61140-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1128
引用
收藏
页码：S445 / S445
页数：1
相关论文
共 50 条
  • [21] ITPA Gene Variant May Protect against Anemia Induced During Pegylated Interferon Alfa and Ribavirin Combination Treatment in Ukrainian Patients with Chronic Hepatitis C
    Kucherenko, A.
    Pampukha, V.
    Bobrova, I.
    Moroz, L.
    Livshits, L.
    CYTOLOGY AND GENETICS, 2015, 49 (02) : 109 - 112
  • [22] ITPA gene variant may protect against anemia induced during pegylated interferon Alfa and Ribavirin combination treatment in Ukrainian patients with chronic hepatitis C
    A. Kucherenko
    V. Pampukha
    I. Bobrova
    L. Moroz
    L. Livshits
    Cytology and Genetics, 2015, 49 : 109 - 112
  • [23] Cost-Effectiveness Assessment of Telaprevir Combination Treatment Compared to Pegylated-Interferon plus Ribavirin Alone in the Management of Hepatitis C in Patients who Failed Prior Pegylated-Interferon plus Ribavirin Treatment
    Deniz, Baris
    Brogan, Anita
    Miller, Jeffrey
    Talbird, Sandra
    Thompson, James
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S410 - S410
  • [24] Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR
    Jafferbhoy, H.
    Miller, M. H.
    El Wahed, Z.
    Dillon, J. F.
    JOURNAL OF HEPATOLOGY, 2011, 55 (05) : 1162 - 1164
  • [25] Baseline factors associated with anemia during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C
    Sampaio, J. P.
    El Batah, P. N.
    Schiavon, L. L.
    Carvalho Filho, R. J.
    Narciso, J. L.
    Ferraz, M. L. G.
    Silva, A. E. B.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S241 - S242
  • [26] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [27] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    HEPATITIS MONTHLY, 2013, 13 (12)
  • [28] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
  • [29] Reply to: "Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR''
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF HEPATOLOGY, 2011, 55 (05) : 1164 - 1166
  • [30] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
12345